These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3793950)

  • 1. Comparison of sustained-release quinidines given twice daily to patients with ventricular ectopy.
    Lehmann CR; Boran KJ; Kruyer WB; Van Reet RE; Scoville GS; Pierson WP; Melikian AP; Crowe JT; Wright GJ
    J Clin Pharmacol; 1986; 26(8):598-604. PubMed ID: 3793950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative quinidine plasma profiles at steady state of two controlled-release products and quinidine sulfate in solution.
    Wright GJ; Melikian AP; Pitts JE; Crowe JT; Morley EM
    Biopharm Drug Dispos; 1987; 8(2):159-72. PubMed ID: 3593896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state bioavailability of two sustained-release quinidine preparations: quinidine gluconate versus quinidine sulfate.
    Taggart WV; Holyoak W
    Clin Ther; 1983; 5(4):357-64. PubMed ID: 6871920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mexiletine and quinidine in ventricular ectopy.
    Fenster PE; Hanson CD
    Clin Pharmacol Ther; 1983 Aug; 34(2):136-42. PubMed ID: 6347497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of spontaneous and exercise-induced ventricular arrhythmias in the absence and presence of treatment with acebutolol or quinidine.
    Shapiro W; Park J; Koch GG
    Am J Cardiol; 1982 Feb; 49(2):445-54. PubMed ID: 6174041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and safety of short-acting and sustained release quinidine in the treatment of patients with ventricular arrhythmias.
    Morganroth J; Hunter H
    Am Heart J; 1985 Dec; 110(6):1176-81. PubMed ID: 4072874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of two manufacturers' sustained-release quinidine gluconate tablets at steady state.
    Zinny MA; Taggart WV
    Clin Ther; 1984; 7(1):22-7. PubMed ID: 6518461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinidine assays: enzyme immunoassay versus high performance liquid chromatography.
    Lehmann CR; Boran KJ; Pierson WP; Melikian AP; Wright GJ
    Ther Drug Monit; 1986; 8(3):336-9. PubMed ID: 3529517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmias.
    Falk RH; O'Brien JL
    Chest; 1984 Oct; 86(4):537-40. PubMed ID: 6383741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous quinidine: relations among concentration, tachyarrhythmia suppression and electrophysiologic actions with inducible sustained ventricular tachycardia.
    Duff HJ; Wyse DG; Manyari D; Mitchell LB
    Am J Cardiol; 1985 Jan; 55(1):92-7. PubMed ID: 3966404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and safety of oral cibenzoline and quinidine in ventricular arrhythmias: a randomized crossover study.
    Wasty N; Saksena S; Barr MJ
    Am Heart J; 1985 Dec; 110(6):1181-8. PubMed ID: 4072875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydroquinidine versus disopyramide: efficacy in patients with chronic stable ventricular ectopy.
    Chimienti M; Panciroli C; Salerno JA; Regazzi-Bonora M; Previtali M; Cristiani D; Rondanelli R; Bobba P
    Clin Cardiol; 1984 Oct; 7(10):538-46. PubMed ID: 6386253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propafenone versus quinidine slow-release for the treatment of chronic ventricular arrhythmias.
    Nielsen H; Sørum C; Rasmussen V; Madsen JK; Hansen JF
    Acta Cardiol; 1990; 45(5):359-63. PubMed ID: 1704168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An experimental model for the rational treatment of arrhythmias: a clinical study with quinidine].
    Pelosi G; Duca G; Bareggi SR; Pirola R; Hadëri B
    G Ital Cardiol; 1993 Aug; 23(8):777-86. PubMed ID: 8119501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinidine plasma concentration and exertional arrhythmia.
    Gey GO; Levy RH; Pettet G; Fisher L
    Am Heart J; 1975 Jul; 90(1):19-24. PubMed ID: 1136935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of lorcainide and quinidine in the treatment of ventricular ectopy.
    Vlay SC; Mallis GI; Singh S; Cohn PF
    Chest; 1984 Jul; 86(1):80-3. PubMed ID: 6734299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of propafenone compared with quinidine in chronic ventricular arrhythmias.
    Dinh HA; Murphy ML; Baker BJ; deSoyza N; Franciosa JA
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1520-4. PubMed ID: 3890510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias.
    Morganroth J; Oshrain C; Steele PP
    Am J Cardiol; 1985 Oct; 56(10):581-5. PubMed ID: 3931448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of high pressure liquid chromatography and fluorescence polarization immunoassay to assess quinidine pharmacokinetics.
    Bottorff MB; Lalonde RL; Straughn AB
    Biopharm Drug Dispos; 1987; 8(3):213-21. PubMed ID: 3297181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial.
    Singh JB; Rasul AM; Shah A; Adams E; Flessas A; Kocot SL
    Am J Cardiol; 1984 Jan; 53(1):84-7. PubMed ID: 6362388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.